On August 17, Astera Labs, Inc. rose 3.23% in pre-market trading, trading at $333.5/share, with turnover of $2.1025 million.

On the news front, the broader semiconductor sector staged a recovery, with Micron Technology up 3.46%, Intel up 2.67%, AMD up 1.49%, Broadcom up 1.27%, and NVIDIA up 0.45%, reflecting a continued repair trend across the industry. Astera Labs moved in tandem with the sector-wide rebound.

From a fundamental perspective, the company previously reported Q2 results that significantly beat expectations, with adjusted EPS of $0.80 versus the $0.69 consensus estimate, and revenue of $392.4 million surpassing the $360.7 million estimate. More notably, Q3 revenue guidance of $540-560 million far exceeded the prior market consensus of $417 million. The strong forward outlook continues to underpin investor confidence. Additionally, RBC Capital raised its price target to $500 from $425 maintaining an Outperform rating, while Morgan Stanley lifted its target to $335 from $240 with an Overweight rating, reinforcing bullish sentiment around the stock.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)